Skip to content
Dx

HCPCS Level II · Medical services and quality measures

M1063Patients receiving high doses of immunosuppressive therapy

Terminated 12/31/2020

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About M1063

M1063 is an HCPCS Level II code in the M series (medical services and quality measures), describing patients receiving high doses of immunosuppressive therapy.

It was added to HCPCS effective 01/01/2019, and its current record took effect 01/01/2021.

It was terminated on 12/31/2020 and can't be billed for later dates of service.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Pt rec hg dos imsup thpy
Date added
01/01/2019
Action effective
01/01/2021
Termination date
12/31/2020
BETOS
Z2

Related M10xx codes

Common questions about M1063

Is HCPCS M1063 still valid?

No. M1063 was terminated on 12/31/2020.

Does Medicare cover M1063?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.